Discontinuation of tenofovir disoproxil fumarate for presumed renal adverse events in treatment-na?ve HIV-1 patients: meta-analysis of randomized clinical studies.
Winston J, Chonchol M, Gallant J, Durr J, Canada RB, Liu H, Martin P, Patel K, Hindman J, Piontkowsky D. Discontinuation of tenofovir disoproxil fumarate for presumed renal adverse events in treatment-na?ve HIV-1 patients: meta-analysis of randomized clinical studies. HIV Clin Trials. 2014 Nov-Dec; 15(6):231-45.